Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease.
about
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.Multi-Lectin Affinity Chromatography for Separation, Identification, and Quantitation of Intact Protein Glycoforms in Complex Biological Mixtures.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
P2860
Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glycosylation of Human Plasma ...... marker of Alzheimer's Disease.
@en
type
label
Glycosylation of Human Plasma ...... marker of Alzheimer's Disease.
@en
prefLabel
Glycosylation of Human Plasma ...... marker of Alzheimer's Disease.
@en
P2093
P50
P921
P1476
Glycosylation of Human Plasma ...... marker of Alzheimer's Disease.
@en
P2093
Chantal Bazenet
Claire Russell
Hui-Chung Liang
Vikram Mitra
P304
P356
10.1021/ACS.JPROTEOME.5B00892
P577
2015-10-21T00:00:00Z